chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client was given Flu vaccine with preservation (FLULAVAL) by accident. There was no unusual signs or symptoms noted after the shot. No treatment was needed.
A Medical Assistant inadvertently gave a 0.5ml volume of the Moderna Covid-19 vaccine to a patient for their booster dose.the dose came from Moderna COVID-19 Vaccine with a red cap and a label with a; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (A Medical Assistant inadvertently gave a 0.5ml volume of the Moderna Covid-19 vaccine to a patient for their booster dose.the dose came from Moderna COVID-19 Vaccine with a red cap and a label with a) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A202A and 058F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2022, the patient experienced ACCIDENTAL OVERDOSE (A Medical Assistant inadvertently gave a 0.5ml volume of the Moderna Covid-19 vaccine to a patient for their booster dose.the dose came from Moderna COVID-19 Vaccine with a red cap and a label with a). At the time of the report, ACCIDENTAL OVERDOSE (A Medical Assistant inadvertently gave a 0.5ml volume of the Moderna Covid-19 vaccine to a patient for their booster dose.the dose came from Moderna COVID-19 Vaccine with a red cap and a label with a) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. it was reported that the dose came from Moderna COVID-19 Vaccine with a red cap and a label with a light blue border. The patient received her first two Moderna Covid-19 vaccines from the State. The patient did not report any adverse reactions or side effects to her first booster dose. Lot number of the vaccine dose incorrectly given is 038A202A expiration date is 30Aug2022. No treatment medication was reported.
Post vaccination, the patient complained of her arm itching within 10 minutes. The patient complained of generalized itching of the arms, legs, face and lips, and 3 hives or rash. After about 40 minutes the patient complained of throat tightness. The patient was treated with Benadryl with some relief in 10 minutes. The patient was transferred by EMS to the ER at 11:02.
pt recv vax; red raised macule papular rash w/ high fever 101,started on chest spreading to extremities w/ discoloration near umbilicies & rt foot; seen by MD & dph prescribed
11 hours after injection, chills, fevers, sweat, extreme body aches, throwing up, headache, fatigue, and swelling at injection sight. I have not been that sick in 15+ years. 48 hours after, there was tightness and tenderness my throat; and swelling and pain of lymph node (right breast). Currently (2 weeks after), still swelling and soreness in lymph node (right breast).
Headache, Arthralgia, Fever, Tachypnea, CoughWheeze, fatigue, nasal congestion Narrative:
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2016, a pharmacist at a pharmacy administered the ZOSTAVAX vaccine to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2018, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
I received my 3rd vaccine on 12/28/2021. My adverse event started on 07/2022. I started experiencing longer periods. On 04/2021 I missed my period for about 1 month. I would miss my periods sometimes for 3-4 months. On 07/2022 I went to my doctor to discuss about this issue. My doctor prescribed me with birth control on August. As of today 12/30/2022 I am still taking it now. My period is back to normal but now I have heavier periods.
Pt received Td shot at 9:30AM on 10/28 in Left deltoid. By that evening, area was very tender. Has been very red, tender and hot for the past 3 1/2 days. Waking her up at night.
Gestational hypertension developed on 1/11. Increased edema of feet, diastolic pressures 95-105. Was sent to the emergency room by the OB team for observation. Was discharged without starting any medications
fever and fatigue  I was told by my Primary Care Physician and Pharmacist that my vaccine was not effective because I received the 2nd dose to soon.   Please note that the pharmacist advised me to report this information because this could have happened to others.    Also, this doctor charged each person $10.00 for each vaccine
Headache within 5 1/2 hours, 103 fever and muscle aches in 12 hours, dizziness within 15 hours, nauseau and vomiting within 16 hours.
felt fine Monday noc & tuesday morning 2JUN98;woke up felt tired achy, had bad h/a, fever 100.8 @ 130PM;took some advil;4PM T102 achy still & still had h/a, took something for fever;Wed morning woke felt better had low temp;sl h/a;arm sore
Woke up at 7am with nausea and light headedness, spent the day with exhaustion, fever (up to 101.3), chills, aches, extreme soreness at injection site, Fever broke at 11pm with Tylenol, Woke up at 1am vomiting, took a Zofran.  Current 36 post vaccine and still feel nauseous and fatigued as well as achy.
Maculopapular rash presented on neck and jaw approximately 6 hours following vaccination. Slightly pruritic, no other symptoms noted. Resolving at the time of this report, following hydrocortisone cream application - approximate duration of 48 hours.
Patient was a first time flu vaccine recipient. Approximately 30 minutes after vaccine administration into left deltoid, patient reported bilateral paresthesia in her palms. She said it was more pronounced in her right palm than her left. This reaction lasted until midday the next day (just over 24 hours after administration).
Headache, Myalgia, Fever, Diarrhea, Fatigue, sore throat, nasalcongestion, chills Narrative:
Headache in the back of my head; Sore on my tongue; Sore on the side of my mouth; swollen lymph nodes; sore arm; This is a spontaneous report from a contactable consumer or other non hcp. A 64-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 27Apr2021 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, sore arm, swollen lymph nodes and sore in the mouth. She received the first Pfizer shot 3 weeks ago. She had a sore arm for 3 days following the dose. She's also been having a headache in back of her head since then. She says the headache stopped yesterday. She now has swollen lymph nodes and a sore in her mouth. Her second dose is scheduled next Tuesday. The outcome of the event was unknown.
Patient was hospitalized on June 17th due to a DVT in the left leg and multiple PE's. Patient had shortness of breath, coughing & wheezing during the months of April and May.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 12-NOV-2015 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K016966, expiration date 10-MAY-2017, dose and route not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion. The total cumulative excursion time was 88 hours, the lowest recorded temperature was 33 Fahrenheit degree and the type of excursion was refrigerator (R). The storage criteria was R. This is one of several reports received from the same source. Additional information has been requested.
devel urticarial rash 29MAR96, 7 days p/vax rash first noted on trunk, large coalesced patches approx 15 to 20 cm in diameter;urticarial rash progressively became gen by the next day;pt irritable, t99 ax;temp reached 102 ax;
This spontaneous report as received from a nurse refers to a patient of unknown age. The patient's medical history was not reported. On an unknown date the patient was vaccinated with LIQUID PEDVAXHIB that was improperly stored. Concomitant medications were not reported. The nurse reported that an improperly stored LIQUID PEDVAXHIB most likely had been administered. The LIQUID PEDVAXHIB reached a temperature as low as 30 Fahrenheit (F) for an unspecified amount of hours. The nurse stated that she thought that the proper storage range for the LIQUID PEDVAXHIB was 35 F to 46 F because she reports that they have always been considered in range at 35F at her office. No adverse effects were reported. The outcome of improperly stored LIQUID PEDVAXHIB have been administered and no adverse effect was unknown. This case is linked to 1406USA009397, 1406USA009398, 1406USA009399 and 1406USA009282. Additional information has been requested.
heaviness and pain on her chest about an hour ago; heaviness and pain on her chest about an hour ago; headache and soreness on her arm; headache and soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (heaviness and pain on her chest about an hour ago), CHEST PAIN (heaviness and pain on her chest about an hour ago), HEADACHE (headache and soreness on her arm) and VACCINATION SITE PAIN (headache and soreness on her arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced CHEST DISCOMFORT (heaviness and pain on her chest about an hour ago), CHEST PAIN (heaviness and pain on her chest about an hour ago), HEADACHE (headache and soreness on her arm) and VACCINATION SITE PAIN (headache and soreness on her arm). At the time of the report, CHEST DISCOMFORT (heaviness and pain on her chest about an hour ago), CHEST PAIN (heaviness and pain on her chest about an hour ago), HEADACHE (headache and soreness on her arm) and VACCINATION SITE PAIN (headache and soreness on her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported.  Treatment medication was not reported.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
As the RN was attempting to inject the vaccine into the patient she noted that the syringe was empty and that the patient did not receive any vaccine. The attending doctor was made aware of the situation and the patient was then vaccinated.
numbness in fingers on both hands; pins and needles sensation in hands; This is a spontaneous report from a contactable consumer, the patient. A 79-years-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 24Feb2021 at 11:30 as a single dose for COVID-19 immunisation. Medical history was reported as no. Concomitant medications of the patient were not reported. Patient had no known allergies.  The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient had not tested for COVID-19. On 04Mar2021 at 07:00 the patient experienced numbness in fingers on both hands, pins and needles sensation in hands. The patient did not receive any treatment for events. Clinical outcome of the events numbness in fingers and pins and needles was unknown at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt recvd vax, then ran a low grade fever; pt was irritable & fussy for up to 1 mo p/immun;
Randomized muscle twitching, anxiety, brain fog, muscle weakness, neck pain, pressure in head
Almost 24 hours after my vaccination, I began to experience a moderate headache throughout almost my entire head. It lasted a little over 5 hours until I took ibeuprofen.  Since then I have experience body aches and muscle weakness. Muscle weakness experienced especially in my extremities. Lastly, I woke up on 3/23 and had moderately severe pain below my ribs in my stomach. It most commonly occurred on my left side and was occasionally felt on my right.
CHILD FELL DOWN WHILE STANDING ABOUT 10 MINUTES AFTER THE VACCINATION WITH Tdap, Menactra and Hep A. Outside the Exam room. Did not pass out, No seizures, No cyanosis, No Injury, stood up at her own. Responding well on floor as well as on standing, PE completely Normal after that. No injury. I called G. ma three hours after at home, child playing and well. No problems.
fever; sore and achy muscles; This is a spontaneous report received from consumer (patient wife) via a Pfizer Sponsored Program COVAX US Support.  This is one of two reports. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot umber was not reported) via an unspecified route of administration on 19Apr021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced fever, sore and achy muscles. Outcome for the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rebound effect from Paxlovid. Finished course, recovered and tested negative for 4 days in a row, then symptoms returned and tested positive for 7 days.; Rebound effect from Paxlovid. Finished course, recovered and tested negative for 4 days in a row, then symptoms returned and tested positive for 7 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07Apr2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 46 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "obesity" (unspecified if ongoing); "known allergies: penicillin" (unspecified if ongoing). Concomitant medication(s) included: OZEMPIC, start date: 01Apr2022. Past drug history included: Aspirin, reaction(s): "Known allergies: aspirin"; Ibuprofen, reaction(s): "Known allergies: ibuprofen". Vaccination history included: moderna (vaccine brand=Other,, vaccine brand other=Moderna,, vaccine brand unknown=False,, vaccine administration date=07Nov2021, vaccine lot unknown=True,, vaccine lot unknown reason=Not available/provided to reporter at the time of report completion,, vaccine dose number=3,, vaccine dose number unknown=False, vaccine location=Right arm), administration date: 07Nov2021, when the patient was 46-year-old, for COVID-19 immunization; Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Apr2022 at 09:00, outcome "recovered" (26Apr2022) and all described as "Rebound effect from Paxlovid. Finished course, recovered and tested negative for 4 days in a row, then symptoms returned and tested positive for 7 days.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Finished course, recovered and tested negative for 4 days in a row, then symptoms returned and tested positive for 7 days; Positive, notes: Finished course, recovered and tested negative for 4 days in a row, then symptoms returned and tested positive for 7 days. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Felt "sickly"; Slept all the time; They Experienced fatigue, tired for about 3 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt "sickly"), SOMNOLENCE (Slept all the time) and FATIGUE (They Experienced fatigue, tired for about 3 days) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 021B21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy (She also reported eye issues and coughing which she relates to pollen.). Concomitant products included ARIPIPRAZOLE (ABILIFY) for Bipolar depression, MIDODRINE for Blood pressure management, BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) for Migraine headache, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), DULOXETINE HYDROCHLORIDE (CYMBALTA), COLECALCIFEROL (VITAMIN D3), CLOPIDOGREL BISULFATE (PLAVIX), LEVOTHYROXINE and METOPROLOL TARTRATE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced ILLNESS (Felt "sickly") and SOMNOLENCE (Slept all the time). On an unknown date, the patient experienced FATIGUE (They Experienced fatigue, tired for about 3 days). At the time of the report, ILLNESS (Felt "sickly") and SOMNOLENCE (Slept all the time) outcome was unknown and FATIGUE (They Experienced fatigue, tired for about 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Products included Adderall for Stimulant to stay awake, Cymbalta for joints, Metoprolol tartrate, Heart medication.   This case was linked to MOD-2021-418050 (Patient Link).
This spontaneous report was received from an 81 year old female patient refers to herself. The patient's pertinent medical history included similar reactions to unspecified steroid medications. Current conditions included unspecified side effects caused by other unspecified medications. On 16-JAN-2014 at 10:30, the patient was vaccinated with ZOSTAVAX injection. Concomitant medications included other unspecified medications that have been taken on a regular basis. The patient explained that after receiving ZOSTAVAX within 5 minutes she became dizzy, felt lightheaded, and had malaise. She felt terrific before receiving the vaccine. Patient stated that the reaction had resolved by 4-5PM the same day. No treatment was given. No laboratory tests were performed. Patient sought medical attention. After being vaccinated the patient contacted her physician who instructed her to lie down for about 1 hour, and therefore she sat in the grocery store for about 1 hour and then drove home, ate, and read until 4-5 PM when she felt that the symptoms had passed. NDC provided: 00006-4963-41. The outcome of lightheaded, malaise and dizzy was reported as recovered/resolved on 16-JAN-2014. Causality assessment was not provided. Additional information has been requested.
p/vax pt devel a 3 inch area of warmth, itching & swelling w/100 papules, appearing as contact dermatitis, @ the site of vax;
pt recv vax & c/o scratchy throat & flushed face;BP 148/96;red, flushed face;BP 138/82;
cough; injection site pain; headache; muscle pains; joint pain; fever, but not a high fever; nausea; feeling freezing cold; chills; ache; cold; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3246), via an unspecified route of administration at left arm on 19Jan2021 08:15 at a single dose for COVID-19 immunization. She was sick (COVID symptoms) all Dec2020 when she was with her sister who had COVID-19. She does not know for sure that she had COVID 19 because she was never tested. She recovered from that illness about two weeks before getting the Pfizer COVID 19 vaccine first dose. The cough was all gone before she had the Pfizer COVID 19 vaccine. No prior vaccinations (within 4 weeks). There were no concomitant medications. The patient had the vaccine on 19Jan2021, two days ago and had not had a problem. She left there and went to the gym for 1 hour afterwards. Then yesterday morning she woke up and has been sick ever since with a cough and chills. She never tested positive for COVID but she was with her sister who had it during Dec2020. She had a cough similar to the one she had in Dec2020 when she was quarantined for COVID symptoms. She was not expecting anything, but it says you can have side effects if you have had COVID-19 so she was calling in about that. On 20Jan2021 she woke up at 02:00 in the morning with a cough; injection site pain which was not sore before; headache; muscle pains, chills; joint pain; fever, but not a high fever; feeling freezing cold; and nausea. She reported 'cold, chills, fever, ache'. She felt a little bit better today on 21Jan2021. She was scheduled to receive the second dose on 15Feb2021 at 08:15. The patient would like to know whether her history of COVID symptoms from Dec2020 may have aggravated her post-vaccination symptoms. The patient would like to know whether there have been other reports of similar post-vaccination as hers. The outcome of the events cough, injection site pain, headache, fever and feeling freezing cold was recovering; event muscle pain, joint pain and nausea was not recovered; event chills was recovered on 21Jan2021; and unknown for the other events.
Increased Glucose levels and A1C    Prior to shot normal  on 9-14-21  went up to 9.2   next test A1C   2-28-22    6.2    Currently  tracked with Lifestyle  as of October 2022  6.1
pt recvd vax; exp itching, bumps & dark marks on arm then spread to underarm, neck;MD dx as of 23jan95,skin condition eczema, rash not due to MMR;